These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19470219)

  • 21. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
    Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Herning RI; Cadet JL; Huestis MA
    J Anal Toxicol; 2009 Oct; 33(8):469-77. PubMed ID: 19874654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
    Desrosiers NA; Lee D; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2014 Jan; 406(3):785-92. PubMed ID: 24292435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.
    Huestis MA; Elsohly M; Nebro W; Barnes A; Gustafson RA; Smith ML
    Ther Drug Monit; 2006 Aug; 28(4):540-4. PubMed ID: 16885722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated extraction and LC-MS-MS analysis of 11-nor-9-carboxy-tetrahydrocannabinol isomers and prevalence in authentic urine specimens.
    Karas LK; Patterson C; Fuller ZJ; Karschner EL
    J Anal Toxicol; 2024 May; 48(4):197-203. PubMed ID: 38581658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials.
    Baker NL; Gray KM; Sherman BJ; Morella K; Sahlem GL; Wagner AM; McRae-Clark AL
    Drug Alcohol Depend; 2018 Jun; 187():270-277. PubMed ID: 29698894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users.
    Smith-Kielland A; Skuterud B; Mørland J
    J Anal Toxicol; 1999 Sep; 23(5):323-32. PubMed ID: 10488918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
    ElSohly MA; deWit H; Wachtel SR; Feng S; Murphy TP
    J Anal Toxicol; 2001 Oct; 25(7):565-71. PubMed ID: 11599601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated extraction of 11-nor-delta9-tetrahydrocannabinol carboxylic acid from urine samples using the ASPEC XL solid-phase extraction system.
    Langen MC; de Bijl GA; Egberts AC
    J Anal Toxicol; 2000 Sep; 24(6):433-7. PubMed ID: 10999349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
    Huestis MA; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
    Milman G; Schwope DM; Schwilke EW; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
    Clin Chem; 2011 Nov; 57(11):1597-606. PubMed ID: 21875944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive cannabis smoke exposure and oral fluid testing.
    Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the impact of hemp food consumption on workplace drug tests.
    Leson G; Pless P; Grotenhermen F; Kalant H; ElSohly MA
    J Anal Toxicol; 2001; 25(8):691-8. PubMed ID: 11765026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papain: a novel urine adulterant.
    Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
    J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Jamerson MH; McCue JJ; Klette KL
    J Anal Toxicol; 2005 Oct; 29(7):627-31. PubMed ID: 16419391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples.
    Skopp G; Pötsch L
    J Anal Toxicol; 2004; 28(1):35-40. PubMed ID: 14987422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of postmortem concentrations of Δ
    Hoffman MA; Trochta A; Gary RD; Fitzgerald RL; McIntyre IM
    Forensic Sci Int; 2020 Oct; 315():110414. PubMed ID: 32738674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.